| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 01/07/2003 | WO2002004664A2 Genes comprising coding mononucleotide microsatellites or dinucleotide microsatellites that can be isolated from tumour cells |
| 01/07/2003 | US6504022 Human bad polypeptides, encoding nucleic acids and methods of use |
| 01/07/2003 | US6503888 AAV-mediated delivery of DNA to cells of the nervous system |
| 01/07/2003 | US6503887 Peroral gene therapy of diabetes and obesity |
| 01/07/2003 | US6503886 Gene delivery; polypeptide conjugated to fibroblast growth factor fused to nucleic acid |
| 01/07/2003 | US6503754 Antisense modulation of BH3 interacting domain death agonist expression |
| 01/07/2003 | US6503753 Method for the development of an HIV vaccine |
| 01/07/2003 | US6503752 Lymphotropic agents and vectors |
| 01/07/2003 | US6503533 Antisense ogligonucleotides against Hepatitis B viral replication |
| 01/07/2003 | US6503504 In vitro cell growth to form tissue containing at least partially foreign DNA sequence which mediates production of the bioactive compound; implanting mass into an organism; treating diseases |
| 01/07/2003 | US6503501 Targetable vector particles |
| 01/07/2003 | US6503499 Viral particle comprising gene of interest operably linked to a promoter and envelope protein affixed with bifunctional adapter and a biotin molecule; internalizing into target cell for transduction and gene expression |
| 01/07/2003 | US6503498 Apolipoprotein A-1 adenovirus vector compositions and methods |
| 01/07/2003 | CA2415199A1 Genes and their genetic products pertinent to microsatellite instable (msi+) tumours |
| 01/07/2003 | CA2182398C Nucleic acid transfection efficiency increase by use of isopropanol in aqueous solutions |
| 01/07/2003 | CA2164844C Methods of preparing gas-filled liposomes |
| 01/07/2003 | CA2089666C Oligonucleotides for modulating the effects of cytomegalovirus infections |
| 01/03/2003 | WO2003001198A1 Immortalization of human cells by the ectopic expression of human telomerase reverse transcriptase |
| 01/03/2003 | WO2003000928A2 Methods for identification of cancer cell surface molecules and cancer specific promoters, and therapeutic uses thereof |
| 01/03/2003 | WO2003000918A2 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof |
| 01/03/2003 | WO2003000907A2 Improved transfection of eukaryotic cells with linear polynucleotides by electroporation |
| 01/03/2003 | WO2003000903A2 Regulation of human nek-like serine/threonine protein kinase |
| 01/03/2003 | WO2003000896A2 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-5 GENE |
| 01/03/2003 | WO2003000894A1 Polynucleotide vaccine |
| 01/03/2003 | WO2003000889A2 Identification of ses-1 and the uses of the same |
| 01/03/2003 | WO2003000859A2 G-protein coupled receptors |
| 01/03/2003 | WO2003000851A2 Method for rapid screening of bacterial transformants and novel simian adenovirus proteins |
| 01/03/2003 | WO2003000846A2 A novel g protein-coupled receptor, gave 3 |
| 01/03/2003 | WO2003000727A2 Atopy |
| 01/03/2003 | WO2003000721A2 Mycobacterial antigens expressed under low oxygen tension |
| 01/03/2003 | WO2003000717A2 Identification of ses-3 (spr-5) in c. elegans and the uses of the same |
| 01/03/2003 | WO2003000656A2 Antisense modulation of transforming growth factor beta receptor ii expression |
| 01/03/2003 | WO2003000297A1 Method of promoting nucleic acid transfer |
| 01/03/2003 | WO2003000296A2 Treatment and diagnostic of b cell chronic lymphocytic leukaemia |
| 01/03/2003 | WO2003000291A1 Lipid vesicles, process for producing lipid vesicles and method of immobilizing gene on lipid vesicles |
| 01/03/2003 | WO2003000283A1 Methods of inducing a cytotoxic immune response and recombinant simian adenovirus compositions useful therein |
| 01/03/2003 | WO2003000280A2 Abin-mediated hepatitis protection |
| 01/03/2003 | WO2003000279A1 GEMININ AND orc3N INHIBIT REPLICATION OF HERPESVIRUSES, PAPILLOMAVIRUSES, AND POLYOMAVIRUSES |
| 01/03/2003 | WO2003000227A2 A method for preparation of vesicles loaded with biological material and different uses thereof |
| 01/03/2003 | WO2003000174A2 Compositions and methods for intracellular delivery |
| 01/03/2003 | WO2003000021A2 Pancam nucleic acids and polypeptides |
| 01/03/2003 | WO2003000014A2 Spherical protein particles and methods of making and using them |
| 01/03/2003 | WO2003000009A2 Stimulation of vascularization with vegf-b |
| 01/03/2003 | WO2002077155A3 Keratinocyte growth factor-2 |
| 01/03/2003 | WO2002072754A9 Mva expressing modified hiv envelope, gag, and pol genes |
| 01/03/2003 | WO2002066489A3 Amphoteric sterols and the use thereof in the production of ph-sensitive liposomes |
| 01/03/2003 | WO2002045755A3 Expression of keratin genes 8 and 18 for treating tumours, in particular a mammary carcinoma |
| 01/03/2003 | WO2002044366A3 Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379 |
| 01/03/2003 | WO2002040635A9 HUMAN RNase H1 MUTANTS |
| 01/03/2003 | WO2002028891A3 Listeria inocua, genome and applications |
| 01/03/2003 | WO2002026209A3 Microparticles for delivery of the heterologous nucleic acids |
| 01/03/2003 | WO2002018536A3 Truncated bard1 protein, and its diagnostic and therapeutic uses |
| 01/03/2003 | WO2002010387A3 G-protein coupled receptors |
| 01/03/2003 | WO2002007759A3 Clostridial toxin derivatives and methods for treating pain |
| 01/03/2003 | WO2002002131A3 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
| 01/03/2003 | WO2001098512A3 Control of metabolism with compositions of the human 2-oxoglutarate carrier |
| 01/03/2003 | WO2001092528A3 Method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 01/03/2003 | WO2001081581A9 Compositions and methods for the therapy and diagnosis of acne vulgaris |
| 01/03/2003 | WO2001081408A9 G-protein coupled receptor (gpcr) agonists and antagonists and methods of activating and inhibiting gpcr using the same |
| 01/03/2003 | WO2001075068A3 Secreted proteins and polynucleotides encoding them |
| 01/03/2003 | CA2489623A1 Atopy |
| 01/03/2003 | CA2489420A1 Oncology drug innovation |
| 01/03/2003 | CA2460809A1 Polynucleotide vaccine |
| 01/03/2003 | CA2459985A1 Pancam nucleic acids and polypeptides |
| 01/03/2003 | CA2452088A1 Compositions and methods for intracellular delivery |
| 01/03/2003 | CA2451864A1 Methods of inducing a cytotoxic immune response and recombinant simian adenovirus compositions useful therein |
| 01/03/2003 | CA2451686A1 A novel g protein-coupled receptor, gave 3 |
| 01/03/2003 | CA2451311A1 Stimulation of vascularization with vegf-b |
| 01/03/2003 | CA2451271A1 Pancam nucleic acids and polypeptides |
| 01/03/2003 | CA2451185A1 Spherical protein particles and methods of making and using them |
| 01/03/2003 | CA2451091A1 A method for preparation of vesicles loaded with biological material and different uses thereof |
| 01/03/2003 | CA2451026A1 Mycobacterial antigens expressed under low oxygen tension |
| 01/03/2003 | CA2450925A1 G-protein coupled receptors |
| 01/03/2003 | CA2447941A1 Novel proteins and nucleic acids encoding same |
| 01/03/2003 | CA2447249A1 Abin-mediated hepatitis protection |
| 01/02/2003 | US20030004326 Fungicides |
| 01/02/2003 | US20030004325 Stability; nuclease resistance |
| 01/02/2003 | US20030004324 31 human secreted proteins |
| 01/02/2003 | US20030004310 Culture product |
| 01/02/2003 | US20030004125 Controlling gene expression; antitumor agent |
| 01/02/2003 | US20030004124 Modulation of apoptosis with nucleic acids; anticancer agents, central nervous system disorders |
| 01/02/2003 | US20030004123 Targeted gene transfer using G protein coupled receptors |
| 01/02/2003 | US20030004110 Therapeutic compositions and methods for enhancing angiogenesis |
| 01/02/2003 | US20030004106 Interleukin-1 receptor antagonist-related molecules and uses thereof |
| 01/02/2003 | US20030004102 Genetic engineering; immunosuppressants, anticancer agents |
| 01/02/2003 | US20030004100 Method of modifying the release profile of sustained release compositions |
| 01/02/2003 | US20030004091 Medicinal combination useful for in vivo exogenic transfection and expression |
| 01/02/2003 | US20030003584 Liposomal vector binding protein for hepatocyte DNA delivery |
| 01/02/2003 | US20030003582 Trans-viral vector mediated gene transfer to the retina |
| 01/02/2003 | US20030003567 Packaging cells |
| 01/02/2003 | US20030003566 Cell line preparing and producing ovine adenovirus vectors |
| 01/02/2003 | US20030003565 Functional lentiviral vector from an MLV-based backbone |
| 01/02/2003 | US20030003547 Controlling homologous recombination; obtain nucleotide sequence, incubate with oligonucleotide, monitor adjustment in gene and phenotypic expression |
| 01/02/2003 | US20030003532 Novel nucleic acid sequences encoding human slit-, megf-, and roundabout-like polypeptides |
| 01/02/2003 | US20030003511 Closure of bacterial ghost |
| 01/02/2003 | US20030003487 Mixed structures resulting from the incorporation of a biological macromolecule, especially of dna, in a liquid crystal phase of amphiphiles, and vesicles obtained using these structures |
| 01/02/2003 | US20030003482 Diagnosing skin disorders and diabetic injury; obtain sample, incubate with probe detect and determine gene expression concentration of preferential gene, amplified gene expression indicates skin disorder |
| 01/02/2003 | US20030003469 Ribozyme treatment of diseases or conditions related to levels of NF-kappaB |
| 01/02/2003 | US20030003466 Artificial mammalian chromosome |
| 01/02/2003 | US20030003462 Novel human interleukin-like proteins and polynucleotides encoding them |